UltraTech Cement Intrinsic Value

ULTRACEMCO • Construction
Current Stock Price
₹12204.00
Primary Intrinsic Value
₹3661.20
Market Cap
₹3600.2K Cr
-70.0% Downside
Median Value
₹3661.20
Value Range
₹2505 - ₹6102
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

ULTRACEMCO Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹3661.20 ₹2928.96 - ₹4393.44 -70.0% EPS: ₹167.48, Sector P/E: 12x
Book Value Method asset ₹2504.85 ₹2254.36 - ₹2755.34 -79.5% Book Value/Share: ₹2504.85, P/B: 1.0x
Revenue Multiple Method revenue ₹3661.20 ₹3295.08 - ₹4027.32 -70.0% Revenue/Share: ₹2682.17, P/S: 0.8x
EBITDA Multiple Method earnings ₹4881.60 ₹4393.44 - ₹5369.76 -60.0% EBITDA: ₹13052.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹4881.60 ₹3905.28 - ₹5857.92 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹3661.20 ₹3295.08 - ₹4027.32 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹3661.20 ₹3295.08 - ₹4027.32 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹6102.00 ₹5491.80 - ₹6712.20 -50.0% ROE: 6.7%, P/E Multiple: 10x
Graham Defensive Method conservative ₹3661.20 ₹3295.08 - ₹4027.32 -70.0% EPS: ₹167.48, BVPS: ₹2504.85
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check ULTRACEMCO share price latest .

Valuation Comparison Chart

ULTRACEMCO Intrinsic Value Analysis

What is the intrinsic value of ULTRACEMCO?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of UltraTech Cement (ULTRACEMCO) is ₹3661.20 (median value). With the current market price of ₹12204.00, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹2504.85 to ₹6102.00, indicating ₹2504.85 - ₹6102.00.

Is ULTRACEMCO undervalued or overvalued?

Based on our multi-method analysis, UltraTech Cement (ULTRACEMCO) appears to be trading above calculated value by approximately 70.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.86 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Debt to Equity Ratio 1.81 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 6.7% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 16.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.59x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹10,673 Cr ₹2,755 Cr Positive Free Cash Flow 7/10
March 2024 ₹10,898 Cr ₹6,504 Cr Positive Free Cash Flow 8/10
March 2023 ₹9,069 Cr ₹5,475 Cr Positive Free Cash Flow 8/10
March 2022 ₹9,283 Cr ₹9,283 Cr Positive Free Cash Flow 8/10
March 2021 ₹12,500 Cr ₹8,072 Cr Positive Free Cash Flow 8/10